Recently, microcephaly cases have increased in Americas and have been matter of concern due to Zika 10 virus (ZIKV) recent outbreak. Previous studies have shown that ZIKV-infected progenitor neuronal 11 cells present morphological abnormalities and increased rates of cell death, which may be indicators of 12 microcephaly causes. As recent studies indicate Zika virus' tropism for brain cells, how would a 13 glioblastoma (GBM) lineage behave under ZIKV infection, considering GBM the most common and 14 malignant brain tumor in adults, presenting extreme chemoresistance and high morbidity and mortality 15 rates? The current trend of using genetically engineered oncolytic pathogens as a safe way to eliminate 16 tumors is under development, with trials already in course. Therefore, the present study evaluated the 17 possible oncolytic effects and metabolomic alterations of Zika virus infection at human malignant 18 M059J glioblastoma cells. Microscopic evaluation was performed using optical microscopy, which 19 showed cytopathic effects induced by ZIKV at GBM cells. For the metabolomics study, both control 20 and infected cell cultures were submitted to MALDI-MSI analysis. Mass spectrometry data were 21 submitted to PLS-DA statistical analysis, and distinct biomarkers were elected for each infected 22
INTRODUCTION 30
The recent outbreak of Zika virus (ZIKV) in Brazil and its outspread through the Americas has 31 brought much concern on the effect that the infection might have on the long term proposed a strong association between mothers infected with ZIKV and newborn's microcephaly 1b, 4 . 36
Currently, the absence of well-established knowledge about the exact mechanisms by which Zika virus 37 affects human brain development is stimulating researches worldwide. . After diagnosis, the prognosis for GBM is generally poor, with 48 patients' presenting an average survival of about 11.5 months; additionally, the overall survival rate 49 after treatment corresponds to less than 10% 8 . Classified as grade IV gliomas, GBMs typically present 50 increased cellular proliferation rate, invasiveness, microvascular proliferation and necrosis, all 51 significantly more intense when compared with more lenient gliomas 9 . The traditional treatment for 52 GBM consists of maximal surgical resection, chemotherapy and radiotherapy. Neverthless, about 90% 53 of surgical resections tumors recur, attesting the surgical incurability of GBMs and reduced life 54 expectancy for these patients 10 .
55
Taking into account the absence of an effective treatment for GBMs, and the ZIKV tropism for brain 56 cells, along with its ability to induce neural cell death, the hypothesis formulated by the present 57 contribution was that ZIKV would provoke cell death in glioblastomas through metabolic changes 58 induced by the viral infection. Therefore, this study aimed at evaluating the metabolomic changes 59 associated with ZIKV infection in glioblastoma cells. In addition, we proposed potential biochemical 60 markers associated with cell death, so that future initiatives may benefit from these characteristics to 61 interfere and improve the approaches for neural cancer treatment. 
Metabolites identification through MALDI-MSI analysis 133
Metabolomics analytical approach was performed for both glioblastoma CT and ZIKV groups, aiming 134 at analyzing the main metabolites involved with ZIKV infection. Mass spectrometric data (Fig. S1 ) 135 were submitted to a PLS-DA, which evidenced differences between metabolite composition in ZIKV-136 infected cells versus uninfected control cells, for both time points of culture, as demonstrated in Fig. 2 . 137
By establishing a threshold value of 1.8 for VIP scores, it was possible to elect biochemical markers 138 for Zika-virus infected group. For the group infected 24 hours post-infection, cells showed an 139 interesting cardiac glycoside (CG) -Digoxin (Table 1) 
160

Digoxin semi-quantification 161
Intending to corroborate the evidence that Digoxin was statistically important for the GBM-ZIKV 162 group, the chemical image for the ion m/z = 779 ( Fig. 3a) was semi-quantified. The statistical analysis 163 is represented in Fig. 3b , providing enough evidence that Digoxin was significantly more expressed in 164
Zika virus infected groups, compared to GBM-CT groups. Digoxin may disrupt ion homeostasis and disturb neuronal excitability, both for healthy and cancer 216 neuronal cells. Furthermore, the sodium-potassium pump inhibitory effect leads to intracellular 217 increase in sodium and calcium levels, which mediates several signaling pathways, including 218 proliferation, differentiation and apoptosis 22b, 23 . Although Na . In case of cancers, negative 237 interference with vascular support for GBM cells is of great value for cancer management, and digoxin 238 induced by Zika virus might be an alternative to weaken tumor cells and reduce glioblastoma growth. 239
Although the exact mechanism of action of cardiac glycosides still needs to be elucidated, Digoxin 240 seems to be a robust candidate for neural cancer management. 241
Although Digoxin was not elected as a significant biomarker for GBM-ZIKV group in the later stage 242 of infection (48 hours post-infection), it indicates that Digoxin was important at the first hours after 243 ZIKV infection. It is likely Digoxin, in the first 24 hours of infection, was synthesized and induced 244 intracellular changes that triggered cell death pathways after 48 hours. The reduction of living cells 245 after 48 hpi impairs digoxin election as a statistical biomarker. Furthermore, the biochemical changes 246 caused by Digoxin might have overlapped its own expression and reduced its significance at statistical 247
analysis. 248
Therefore, the present study has shown that malignant glioblastoma cells were susceptible to ZIKV 249 infection, which was verified through cytopathic effects over infection time. Therefore, microscopic 250 observations combined with the metabolomics data revealed in the present study suggest that Digoxin, . Therefore, the use of 277 oncolytic viruses is a promising strategy, and further studies must be taken forward to verify the link 278 between synthesis of Digoxin and Zika virus infection. ZIKV may be, therefore, ultimately genetically 279 engineered and be a strong alternative to glioblastoma management, in an effort to provide better 280 quality of life and survival rates for these patients. 281
In addition to the possibility of using ZIKV for neural cancer management, an alternative to explore 
